• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Howard I. Scher, Susan Halabi, +17 authors Maha Hussain
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2008 (First Publication: 1 March 2008)
  • PURPOSE To update eligibility and outcome measures in trials that evaluate systemic treatment for patients with progressive prostate cancer and castrate levels of testosterone. METHODS A committeeExpand
  • Glenn J. Bubley, M Carducci, +22 authors Greg Wilding
  • Medicine
  • Journal of clinical oncology : official journal…
  • 1999 (First Publication: 1 November 1999)
  • PURPOSE Prostate-specific antigen (PSA) is a glycoprotein that is found almost exclusively in normal and neoplastic prostate cells. For patients with metastatic disease, changes in PSA will oftenExpand
  • Josep Domingo-Doménech, Samuel J. Vidal, +11 authors Carlos Cordon-Cardo
  • Medicine, Biology
  • Cancer cell
  • 2012 (First Publication: 11 September 2012)
  • Acquired resistance to Docetaxel precedes fatality in hormone-refractory prostate cancer (HRPC). However, strategies that target Docetaxel resistant cells remain elusive. Using in vitro and in vivoExpand
  • Maha H A Hussain, Catherine M. Tangen, +5 authors E. David Crawford
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2005 (First Publication: 1 December 2005)
  • PURPOSE The epothilones are a new class of tubulin-polymerizing agents with activity in taxane-sensitive and resistant tumor models. We evaluated ixabepilone (BMS-247550) in patients with metastaticExpand
  • Maha H A Hussain, Gary R. Macvicar, +9 authors David C Smith
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2007 (First Publication: 1 June 2007)
  • PURPOSE We investigated the safety and efficacy (response rates, time to disease progression, survival) of trastuzumab, carboplatin, gemcitabine, and paclitaxel in advanced urothelial carcinomaExpand
  • Supriya G Mohile, Kathryn A. Bylow, +5 authors Miriam B. Rodin
  • Medicine
  • Cancer
  • 2007 (First Publication: 15 February 2007)
  • BACKGROUND Impairments in geriatric domains adversely affect health outcomes of the elderly. The Comprehensive Geriatric Assessment (CGA) is a key component of the treatment approach for older cancerExpand